Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Roche and Merck collaborate on personalised cancer tests

June 8, 2011 Research and Development Merck, Roche, personalised medicine

Roche has signed a deal to develop diagnostic tests for products in Merck’s oncology pipeline, in a bid to make …
News

Promoting UK biotech’s voice and mission

June 8, 2011 Research and Development ERBI, One Nucleus, biotech

One Nucleus is a new organisation formed from the merger of two of England’s regional networks – ERBI (Eastern Region …
Feature

Merck plans cancer drug submissions later this year

June 7, 2011 Research and Development, Sales and Marketing Merck & Co, ridaforolimus

Merck & Co is to submit its oral investigational cancer drug ridaforolimus to European and US regulators later this year …
News
Merck Serono headquarters

Erbitux meets gold standard in rectal cancer

June 7, 2011 Research and Development, Sales and Marketing Erbitux, Merck Serono, rectal cancer

Studies of Merck Serono’s Erbitux in rectal cancer have shown improved overall survival, a gold standard measure in oncology trials. …
News
Roche

Roche impresses at ASCO with vemurafenib

June 6, 2011 Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …
News
Pfizer

Pfizer simplifies contract research with Parexel and Icon

May 27, 2011 Research and Development ICON, Parexel, Pfizer, cros

Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …
News

J&J aims for Japanese pharma expansion

May 27, 2011 Research and Development, Sales and Marketing J&J, JJ

Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …
News

British biotech: rebuilding momentum

May 26, 2011 Research and Development UK, biotech, biotech funding

Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …
Feature

Elan signs $20m research deal with Proteostasis

May 25, 2011 Research and Development Elan, Proteostasis, neurodegenerative diseases

Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …
News

Eisai extends neuroscience partnership with UCL

May 25, 2011 Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases

Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …
News

Contract research news in brief

May 25, 2011 Research and Development contract research, contract research news

Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …
News
GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011 Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
News

Pfizer’s cancer drug meets end points in head-to-head study

May 20, 2011 Research and Development, Sales and Marketing Pfizer, axitinib, rcc

Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
News

Blood cancer charity to kick-start clinical trials

May 19, 2011 Research and Development Cancer, blood cancer, clinical trials, leukaemia

A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …
News
Roche

MetMab produces exciting results in lung cancer patients

May 19, 2011 Research and Development MetMAb, Roche

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025